Immuneering Corp Long-term Investment Intensity

Latest as of December 2021: 0.6%

Immuneering Corp long-term investment intensity. Immuneering Corp (IMRX) has a Long-term Investment Intensity of 0.6% as of December 2021. Long-term investments of $996.56K represent 0.6% of total assets of $166.70 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read IMRX current and long-term liabilities for a breakdown of total debt and financial obligations.

LT Investment Intensity

0.6%
LT Investments / Total Assets

Long-term Investments

$996.56K
USD

Total Assets

$166.70 Million
USD

Country

USA
NASDAQ

Long-term Investment Intensity of Immuneering Corp (2021–2021)

Long-term investment intensity of Immuneering Corp from 2021 to 2021. This chart shows how Immuneering Corp's Long-term Investment Intensity has evolved across 1 annual periods from 2021 to 2021. As of December 2021, the intensity stands at 0.6%, reflecting long-term investments of $996.56K against total assets of $166.70 Million USD.

Immuneering Corp Long-term Investment Intensity by Year (2021–2021)

Immuneering Corp long-term investment intensity by year from 2021 to 2021. The table below presents the year-by-year Long-term Investment Intensity for Immuneering Corp from 2021 to 2021, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see IMRX current and non-current assets.

Year LT Investment Intensity LT Investments (USD) Total Assets Change (pp)
2021 0.6% $996.56K $166.70 Million —
pp = percentage points